NetworkNewsBreaks

TuesdayJun 09, 2026 9:00 am

NetworkNewsBreaks – Bezos Says Space-Based Data Centers Are Coming, but Not Anytime Soon

NVIDIA Corp. (NASDAQ: NVDA) could eventually play a critical role in the development of orbital data centers, but Amazon founder Jeff Bezos believes the industry’s most optimistic timelines are unrealistic due to significant economic hurdles. Speaking about the future of space-based computing infrastructure, Bezos said that while data centers in orbit are likely to become a reality, the high cost of advanced AI chips and the expense of launching hardware into space remain major obstacles. Interest in orbital data centers continues to grow because they could leverage abundant solar energy and avoid the land-use challenges increasingly associated with terrestrial facilities. However,…

Continue Reading

MondayJun 08, 2026 2:49 pm

NetworkNewsBreaks – Roth Capital Partners to Host 16th Annual London Conference Featuring 80+ Growth Companies 

Roth Capital Partners will host its 16th Annual ROTH London Conference June 16-18, 2026, at the Four Seasons Hotel London at Park Lane, bringing together institutional investors and executives from more than 80 companies across the sustainability, technology, energy, digital infrastructure, engineering and mining sectors. The invitation-only event will feature one-on-one and small-group meetings designed to provide investors with direct access to company leadership teams and insight into growth strategies, operations and capital formation opportunities.  The conference agenda includes presentations from ARK Investment Management Founder and CEO Cathie Wood, ROTH Chief Economist Michael Darda and Chief Technical Strategist JC O'Hara. Organizers said discussions will focus on sectors…

Continue Reading

MondayJun 08, 2026 2:43 pm

NetworkNewsBreaks – Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) Secures Strategic Investment from VisionWave to Advance AI-Powered Defense Technologies 

Foresight (NASDAQ: FRSX) (TASE: FRSX) announced a definitive agreement with VisionWave Holdings (NASDAQ: VWAV) for a strategic equity investment of up to $17.5 million in VisionWave common stock, reflecting a post-investment valuation of approximately $34 million for Foresight. The companies plan to combine Foresight’s visible light, infrared and neuromorphic sensing technologies with VisionWave’s artificial intelligence and radio frequency-based perception systems to develop advanced solutions for defense and security applications. Under the agreement, VisionWave is expected to acquire a controlling 52% stake in Foresight through a two-stage transaction and gain representation on the company's board of directors, subject to shareholder and regulatory approvals. The collaboration is intended to accelerate the development and commercialization of AI-enhanced perception platforms…

Continue Reading

MondayJun 08, 2026 1:15 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in a virtual investor segment featuring Chief Financial Officer Steve O'Loughlin, who discussed the company's recently completed oversubscribed $22.5 million financing. The presentation focused on the factors supporting the successful capital raise following CNS Pharmaceuticals' strategic reset and acquisition-focused transformation. Management also addressed investor reception to the company's evolving strategy, the participation of healthcare-focused institutional investors and how the strengthened balance sheet positions CNS Pharmaceuticals to pursue potential transformational opportunities. The discussion highlighted the company's long-term growth strategy and efforts to create shareholder value as it advances its next phase of development. To…

Continue Reading

MondayJun 08, 2026 11:59 am

NetworkNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances European Commercial Launch Plans for GelrinC

Regentis Biomaterials (NYSE American: RGNT) announced plans to begin European surgeon training activities in the third quarter of 2026 as part of preparations for the commercial rollout of GelrinC(R), its CE Mark-approved treatment for knee cartilage lesions. The hands-on program will provide orthopedic surgeons with practical experience using the company's cell-free implant and is expected to begin at Humanitas Research Hospital in Milan, Italy, with additional sessions planned across Europe. The company said the training initiative is a key step in its European commercialization strategy and will be supported by a network of Centers of Excellence focused on surgeon education, clinical guidance and knowledge sharing. GelrinC is designed as…

Continue Reading

MondayJun 08, 2026 11:45 am

NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Advances Ibogaine Drug Development Program 

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.  Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) announced progress on its Ibogaine Initiative, securing naturally derived ibogaine from two sources in both hydrochloride and freebase forms. The company expects development of finished ibogaine drug products to begin this summer at its GMP-certified manufacturing facility in British Columbia, with plans to produce standardized 50 mg and 100 mg encapsulated dosage formats for research and regulated access programs. The update comes amid growing interest in ibogaine research and expanding public funding for psychedelic therapies, including a recently announced $50 million program in Texas. Optimi said its development program…

Continue Reading

MondayJun 08, 2026 11:34 am

NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Signs LOI to Advance ONC010 Development, Appoints VP of Corporate Finance 

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.  Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced it has entered into a non-binding letter of intent with Nanosoft Polymers as an initial step toward negotiating a services agreement supporting development of its exclusively licensed PNKP inhibitor technology, ONC010. The proposed collaboration would focus on polymer process development, analytical characterization, formulation optimization and manufacturing planning activities designed to support future clinical and regulatory development of the oncology candidate.  The company also appointed Dave Antony as vice president of corporate finance. Antony brings more than 35 years of experience in financial planning, reporting, corporate governance and public company advisory services, including leadership roles…

Continue Reading

MondayJun 08, 2026 9:50 am

NetworkNewsBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) Emerging as Mission-Critical AI and Cybersecurity Platform Amid Expanding Government, Defense Opportunities

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) is gaining traction as a specialized artificial intelligence platform serving government, public safety, defense and healthcare markets, leveraging proprietary chemistry-focused AI models, scientific datasets and operational intelligence tools designed for mission-critical environments. The company has established partnerships with Canadian government agencies, law enforcement organizations and public safety initiatives, while advancing defense-related applications through its Q-SAFE hazardous chemical risk classification program and a proposed acquisition of quantum cybersecurity firm Quantum.IQ. Redwood joins a growing group…

Continue Reading

MondayJun 08, 2026 9:30 am

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Delivers AI-Powered Threat Detection System Under U.S. Army Contract

Safe Pro Group (NASDAQ: SPAI) announced it has fulfilled a U.S. Army order valued at approximately $743,000 for its AI-powered Threat Analysis Kit, which combines the company’s NODE edge-computing platform with Black Widow(TM) drones from Red Cat Holdings (NASDAQ: RCAT). The field-ready battlefield intelligence system is designed to process drone-captured video and rapidly identify threats such as landmines, unexploded ordnance, cluster munitions and hostile drones, while generating detailed 2D and 3D battlefield maps for situational awareness. The award follows a recent subcontract from a defense prime contractor to provide the U.S. Army with battlefield intelligence capabilities powered by Safe Pro’s…

Continue Reading

MondayJun 08, 2026 9:20 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Showcase AI Drug Discovery Platform at Qdrant Vector Space Day 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced that its proprietary PDAOAI(TM) drug discovery and development platform will be featured during the Product & Engineering keynote at Qdrant Vector Space Day 2026 in San Francisco on June 11. Company executives will join Qdrant leadership to discuss how PDAOAI, operating on Qdrant infrastructure, has helped accelerate the development of two drug candidates from concept to investigational new drug filings in less than two years, significantly reducing the time and cost traditionally associated with pharmaceutical development. The presentation will highlight several innovations underpinning the platform, including a proprietary "manifold folding" technique designed to improve semantic…

Continue Reading